The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA as an early response indicator in anal squamous cell carcinoma treated with chemoradiation.
 
Aron Bercz
No Relationships to Disclose
 
Janet Alvarez
No Relationships to Disclose
 
Caroline Kostrzewa
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Vasily Aushev
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Adham Jurdi
Employment - Natera
Stock and Other Ownership Interests - Agenus; Iovance Biotherapeutics; natera; Verastem
 
John Cuaron
No Relationships to Disclose
 
Melissa Zinovoy
No Relationships to Disclose
 
Christopher Crane
Stock and Other Ownership Interests - Oncternal Therapeutics
Honoraria - Elekta
Consulting or Advisory Role - TriSalus Life Sciences
Research Funding - Elekta (Inst)
 
Neil Segal
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Novartis; Numab; PureTech; Revitope
Research Funding - Agenus; AstraZeneca; Bristol Myers Squibb Foundation; Genentech; Immunocore; Merck; Pfizer; PureTech; Regeneron; Roche
Travel, Accommodations, Expenses - AstraZeneca; MedImmune; Regeneron
 
Rona Yaeger
Consulting or Advisory Role - Loxo@Lilly; Mirati Therapeutics; Revolution Medicines
Research Funding - Boehringer Ingelheim (Inst); Boundless Bio (Inst); Daiichi Sankyo/UCB Japan (Inst); Mirati Therapeutics (Inst); Pfizer (Inst)
 
Andrea Cercek
Stock and Other Ownership Interests - Haystack Oncology
Consulting or Advisory Role - Abbvie; Agenus; Daiichi Sankyo/Astra Zeneca; G1 Therapeutics; GlaxoSmithKline; Incyte; Janssen; Merck; Regeneron; Roche/Genentech; Seagen
Research Funding - GlaxoSmithKline; Seagen
Patents, Royalties, Other Intellectual Property - Hepatic arterial infusion with FUDR for colorectal liver metastases with DPD (Inst); Hepatic arterial infusion with FUDR for colorectal liver metastases with DPD (Inst); Neoadjuvant PD1 blockade in mismatch repair deficient solid tumors (Inst)
 
Christine Olinger
No Relationships to Disclose
 
Jorge Marcet
Consulting or Advisory Role - Baxter; Medtronic; Stryker
Speakers' Bureau - Intuitive Surgical
 
Philip Paty
No Relationships to Disclose
 
Martin Weiser
Patents, Royalties, Other Intellectual Property - UpToDate Section Editor
 
Julio Garcia-Aguilar
Stock and Other Ownership Interests - Intuitive surgical
 
Mithat Gonen
Travel, Accommodations, Expenses - Genentech
 
Jesse Joshua Smith
Consulting or Advisory Role - Foundation Medicine; GlaxoSmithKline; Guardant Health
Travel, Accommodations, Expenses - GlaxoSmithKline
Other Relationship - Johnson & Johnson/Janssen
 
Richard Tuli
No Relationships to Disclose
 
Paul Romesser
Employment - Memorial Sloan-Kettering Cancer Center
Consulting or Advisory Role - EMD Serono; Faeth Therapeutics; Natera
Research Funding - X-RAD Therapeutics (Inst)
(OPTIONAL) Uncompensated Relationships - Anal Cancer Foundation; HPV Alliance